Izelle Labuschagne
Izelle Labuschagne
School of Behavioural and Health Sciences, Australian Catholic University, Victoria, Australia
Verified email at
Cited by
Cited by
Oxytocin attenuates amygdala reactivity to fear in generalized social anxiety disorder
I Labuschagne, KL Phan, A Wood, M Angstadt, P Chua, M Heinrichs, ...
Neuropsychopharmacology 35 (12), 2403-2413, 2010
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study
DJH Moss, AF Pardi˝as, D Langbehn, K Lo, BR Leavitt, R Roos, A Durr, ...
The Lancet Neurology 16 (9), 701-711, 2017
The wisdom to know the difference: Strategy-situation fit in emotion regulation in daily life is associated with well-being
SJ Haines, J Gleeson, P Kuppens, T Hollenstein, J Ciarrochi, ...
Psychological Science 27 (12), 1651-1659, 2016
Modulation of resting-state amygdala-frontal functional connectivity by oxytocin in generalized social anxiety disorder
S Dodhia, A Hosanagar, DA Fitzgerald, I Labuschagne, AG Wood, ...
Neuropsychopharmacology 39 (9), 2061-2069, 2014
Oxytocin enhances resting-state connectivity between amygdala and medial frontal cortex
CS Sripada, KL Phan, I Labuschagne, R Welsh, PJ Nathan, AG Wood
International Journal of Neuropsychopharmacology 16 (2), 255-260, 2013
The cognitive burden in Huntington's disease: pathology, phenotype, and mechanisms of compensation
M Papoutsi, I Labuschagne, SJ Tabrizi, JC Stout
Movement Disorders 29 (5), 673-683, 2014
Medial frontal hyperactivity to sad faces in generalized social anxiety disorder and modulation by oxytocin
I Labuschagne, KL Phan, A Wood, M Angstadt, P Chua, M Heinrichs, ...
International Journal of Neuropsychopharmacology 15 (7), 883-896, 2012
Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington's disease
JC Stout, R Jones, I Labuschagne, AM O'Regan, MJ Say, EM Dumas, ...
Journal of Neurology, Neurosurgery & Psychiatry 83 (7), 687-694, 2012
Oxytocin modulation of amygdala functional connectivity to fearful faces in generalized social anxiety disorder
SM Gorka, DA Fitzgerald, I Labuschagne, A Hosanagar, AG Wood, ...
Neuropsychopharmacology 40 (2), 278-286, 2015
MSH3 modifies somatic instability and disease severity in Huntington’s and myotonic dystrophy type 1
M Flower, V Lomeikaite, M Ciosi, S Cumming, F Morales, K Lo, ...
Brain 142 (7), 1876-1886, 2019
Compensation in preclinical Huntington's disease: evidence from the track-on HD study
S Kl÷ppel, S Gregory, E Scheller, L Minkova, A Razi, A Durr, RAC Roos, ...
EBioMedicine 2 (10), 1420-1429, 2015
Oxytocin and brain activity in humans: a systematic review and coordinate-based meta-analysis of functional MRI studies
SA Grace, SL Rossell, M Heinrichs, C Kordsachia, I Labuschagne
Psychoneuroendocrinology 96, 6-24, 2018
Safety, tolerability, and efficacy of PBT2 in Huntington's disease: a phase 2, randomised, double-blind, placebo-controlled trial
Huntington Study Group Reach2HD Investigators
The Lancet Neurology 14 (1), 39-47, 2015
Task characteristics influence facial emotion recognition age-effects: A meta-analytic review.
GS Hayes, SN McLennan, JD Henry, LH Phillips, G Terrett, PG Rendell, ...
Psychology and aging 35 (2), 295, 2020
An introductory guide to conducting the Trier Social Stress Test
I Labuschagne, C Grace, P Rendell, G Terrett, M Heinrichs
Neuroscience & Biobehavioral Reviews 107, 686-695, 2019
Executive function in body dysmorphic disorder
J Dunai, I Labuschagne, DJ Castle, M Kyrios, SL Rossell
Psychological medicine 40 (9), 1541-1548, 2010
Brain regions showing white matter loss in Huntington’s disease are enriched for synaptic and metabolic genes
P McColgan, S Gregory, KK Seunarine, A Razi, M Papoutsi, E Johnson, ...
Biological psychiatry 83 (5), 456-465, 2018
Decision-making ability in current and past users of opiates: A meta-analysis
K Biernacki, SN McLennan, G Terrett, I Labuschagne, PG Rendell
Neuroscience & Biobehavioral Reviews 71, 342-351, 2016
The impact of occipital lobe cortical thickness on cognitive task performance: An investigation in Huntington's Disease
EB Johnson, EM Rees, I Labuschagne, A Durr, BR Leavitt, RAC Roos, ...
Neuropsychologia 79, 138-146, 2015
Emotional face recognition deficits and medication effects in pre-manifest through stage-II Huntington's disease
I Labuschagne, R Jones, J Callaghan, D Whitehead, EM Dumas, MJ Say, ...
Psychiatry research 207 (1-2), 118-126, 2013
The system can't perform the operation now. Try again later.
Articles 1–20